Article

amny.com on 2020-08-25 15:30

AstraZeneca starts trial of COVID-19 antibody treatment

BY PUSHKALA ARIPAKA AND AAKASH B British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19,

Related news

AstraZeneca starts trial of antibody treatment for COVID-19 The Jerusalem Post (JPost.com)
United States , United Kingdom
AstraZeneca antibody cocktail fails to prevent COVID-19 in large trial The Jerusalem Post (JPost.com)
Switzerland , United States , United Kingdom
AstraZeneca COVID-19 vaccine trial data questioned; antibody cocktail reduces hospitalizations, deaths: Coronavirus update for Wednesday, March 24 cleveland.com
United Kingdom , Spain , Italy , Germany , France
AstraZeneca antibody cocktail study shows success treating COVID-19 amny.com
United States , Delaware , Wilmington , North America
MRegeneron’s antibody drug is the first specifically-designed COVID-19 treatment added to leading U.K. trial marketwatch.com
Phase 2 , The National
Eli Lilly pharma giant pauses trial of antibody treatment for covid-19 israelnationalnews.com
Covid-19 antibody treatment trial to ...Shropshire Star
Europe , South America , North America
AstraZeneca asks FDA to authorize COVID antibody treatment lasvegassun.com
Texas , Louisiana , Florida
AstraZeneca antibody cocktail succeeds in late-stage study to treat COVID-19, company says Sydney Morning Herald
United States
AstraZeneca seeks FDA approval for COVID-19 antibody treatment bradenton.com
Europe
AstraZeneca asks FDA to authorize COVID-19 antibody treatment journalrecord.com
Oklahoma City , Oklahoma
AstraZeneca Covid-19 antibody treatment ‘more effective than vaccines’theweek.co.uk
NAll about monoclonal antibody drugs — the experimental treatment that may have turned Trump's COVID-19 around nationalpost.com
New York , Tarrytown , West Chester , California , La Jolla